AtriCure Corp (ATRC) - Forward Price-to-Revenue Multiple

atricure.com (ATRC) - corporate logo

Physician loyalty to AtriCure, Inc. (ATRC) probes creates stable demand for consumables, which is reflected in the forward P/S ratio. The 3.00 indicator expresses the state of the metric, capturing trend reversals. Business resilience is based on precision outsourcing of components with final assembly conducted in-house. Revenue growth is driven by the implementation of minimally invasive arrhythmia treatment techniques and systematic surgeon training.

ATRC atricure.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

AtriCure Medical - analytical breakdowns and key metrics (ATRC)

- market price and analyst price targets:
Price Chart AtriCure|ATRC - Fair Value Consensus
- market capitalization indicators:
Market Valuation AtriCure Medical|ATRC - Enterprise Value
- business book valuation details:
Net Assets per Single Share AtriCure|ATRC - Company Net Assets|Market Capitalization to Book Value Ratio atricure.com|ATRC - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity AtriCure, Inc.|ATRC - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio AtriCure, Inc.|ATRC - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio AtriCure Medical|ATRC - Long-Term Debt Volume|Company Short-Term Debts AtriCure|Quick Liquidity Indicator atricure.com
- business earnings and investment ratios data:
ATRC - Profit After Payment of Taxes|Expected Profit AtriCure, Inc.|ATRC - Company Value to Net Income|Forward P/E Multiple AtriCure Corp|ATRC - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple AtriCure Medical|ATRC - Operating profit before deduction of amortization|Net earnings per share for the last 12 months AtriCure|ATRC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months atricure.com|ATRC - Earnings per share increase in current year|Earnings growth forecast for next year AtriCure, Inc.
- sales and revenue data:
ATRC - Company Total Revenue|Company Future Sales Volume AtriCure|ATRC - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple AtriCure Medical
General company analysis:ATRC (AtriCure)
Original product of atricure.com

AtriCure, Inc. (ATRC) proprietary high-tech manufacturing facilities in the US guarantee supply stability for cardiac centers, establishing a foundation for revenue forecasting. The forward price-to-sales valuation compares current market capitalization with expected sales to identify risks of systemic business decline. Analyzing this metric allows investors to distinguish genuine undervaluation from a "value trap" via the multiplier's dynamics. This helps investors determine the fair cost of capital over a long-term horizon.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (icumed.com)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Vascular Inc LMAT|STAA: Forward P/S Multiple|Niagen (NAGE) - Forward P/S Multiple|Forward Price-to-Revenue Multiple ZIMV|ANGO (angiodynamics.com) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Cerus (CERS)|TKNO (Alpha Teknova) - Forward Price to Sales|Forward P/S Multiple MGRM (Monogram Technologies Inc)|Market Cap to Expected Sales Ratio Sharps Technology Inc (STSS)|InfuSystem Inc - Forward P/S Multiple|utahmed.com (UTMD) - Forward Price-to-Revenue Multiple|KRMD (korumedical.com) - Forward Price-to-Revenue Multiple|Nyxoah SA (NYXH) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Microbot Medical Inc|PDEX: Forward Price to Sales|Forward P/S Multiple ZTEK|ELUT - Market Cap to Future Revenue Ratio|Milestone Scientific Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales NXGL|Retractable Tech - Forward P/S Multiple|Market Cap to Expected Sales Ratio harvardbioscience.com HBIO|Femasys Inc. (FEMY) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue MHUA|POAI (Predictive Oncology Inc) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Callan JMB Corp (CJMB)|Forward Price-to-Revenue Multiple ATRI (Atrion Corp)|Market Cap to Expected Sales Ratio NeuroMetrix Corporation